JNJ FCF Margin
Free cash flow as a percentage of revenue, showing how much of each sales dollar becomes cash.
FCF Margin
Latest: 28.8% (2026Q2)
| Period | Value |
|---|---|
| 2020Q3 | 36.3% |
| 2020Q4 | 32.1% |
| 2021Q1 | 17.9% |
| 2021Q2 | 19.5% |
| 2021Q3 | 32.4% |
| 2021Q4 | 44.7% |
| 2022Q1 | 15.5% |
| 2022Q2 | 19.9% |
| 2022Q3 | 26.7% |
| 2022Q4 | 31.8% |
| 2023Q1 | 11.6% |
| 2023Q2 | 14.6% |
| 2023Q3 | 31.1% |
| 2023Q4 | 29.9% |
| 2024Q1 | 14.3% |
| 2024Q2 | 22.4% |
| 2024Q3 | 31.2% |
| 2024Q4 | 24.1% |
| 2025Q1 | 16.7% |
| 2025Q2 | 12.2% |
| 2025Q3 | 33.7% |
| 2025Q4 | 22.3% |
| 2026Q1 | 6.1% |
| 2026Q2 | 28.8% |
Other JNJ Charts
More quarter-by-quarter fundamentals for Johnson & Johnson
1 / 10
Revenue
EPS
Free Cash Flow
Gross Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Total Assets
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Latest FCF Margin: 28.8% (2026Q2); +16.7 pp YoY.
Across the 62 quarters from 2011Q1 to 2026Q2, FCF Margin ranged from 6.1% in 2026Q1 to 44.7% in 2021Q4.
Chart and table show the latest 24 of 62 quarters.